SE0202346D0 - Profiling process - Google Patents

Profiling process

Info

Publication number
SE0202346D0
SE0202346D0 SE0202346A SE0202346A SE0202346D0 SE 0202346 D0 SE0202346 D0 SE 0202346D0 SE 0202346 A SE0202346 A SE 0202346A SE 0202346 A SE0202346 A SE 0202346A SE 0202346 D0 SE0202346 D0 SE 0202346D0
Authority
SE
Sweden
Prior art keywords
protein
present
bio
steps
isolated
Prior art date
Application number
SE0202346A
Other languages
English (en)
Inventor
Gyoergy Marko-Varga
Thomas Fehniger
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202346A priority Critical patent/SE0202346D0/sv
Publication of SE0202346D0 publication Critical patent/SE0202346D0/sv
Priority to PCT/SE2003/001244 priority patent/WO2004011664A2/en
Priority to AU2003251261A priority patent/AU2003251261A1/en

Links

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE0202346A 2002-07-30 2002-07-30 Profiling process SE0202346D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0202346A SE0202346D0 (sv) 2002-07-30 2002-07-30 Profiling process
PCT/SE2003/001244 WO2004011664A2 (en) 2002-07-30 2003-07-30 Protein or carbohydrate profiling
AU2003251261A AU2003251261A1 (en) 2002-07-30 2003-07-30 Protein or carbohydrate profiling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202346A SE0202346D0 (sv) 2002-07-30 2002-07-30 Profiling process

Publications (1)

Publication Number Publication Date
SE0202346D0 true SE0202346D0 (sv) 2002-07-30

Family

ID=20288660

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202346A SE0202346D0 (sv) 2002-07-30 2002-07-30 Profiling process

Country Status (3)

Country Link
AU (1) AU2003251261A1 (sv)
SE (1) SE0202346D0 (sv)
WO (1) WO2004011664A2 (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359649A1 (en) * 1999-02-16 2000-08-24 Lance A. Liotta Lcm (laser capture microdissection) for cellular protein analysis
DE60028393T2 (de) * 1999-07-26 2007-06-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Schichtvorrichtung mit einfangbereichen zur zellulären analyse

Also Published As

Publication number Publication date
AU2003251261A1 (en) 2004-02-16
WO2004011664A2 (en) 2004-02-05
AU2003251261A8 (en) 2004-02-16
WO2004011664A3 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
BRPI9912227B1 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
CY1113247T1 (el) Νουκλεϊνικα οξεα με τιτλο 273ρ4β7 και η χρηση τους στην ανιχνευση καρκινου
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
EA201301072A1 (ru) Антитела против il-23p19 и их применение
WO2003014303A3 (en) Molecular interactions in cells
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
ATE291086T1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
HUP0400697A2 (hu) Elcsendesített anti-CD28 ellenanyagok és használatuk
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
JP2006506095A5 (sv)
WO2001093851A3 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
ATE456799T1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
SE0202346D0 (sv) Profiling process
IL151620A0 (en) Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
NO20040174L (no) Fremgangsmate for donorspesifikk krysstilpasning
DE60117788D1 (de) Menschliche wingless-änhliche gene
DK1263787T3 (da) G-proteinkoblet receptor
MXPA02004825A (es) Genes especificamente expresados en celulas dendriticas humanas.
DE10296200D2 (de) Verfahren zur Diagnose von Brustkrebserkrankungen, zugehörige Peptide und deren Verwendungen
DE50113417D1 (de) Zellbindende nukleinsäuremoleküle (aptamere)
AR023794A1 (es) Antigeno asociado con tumores
DE602005006607D1 (de) Peptide mit der fähigkeit, die in tumorzellen gebildeten isoformproteinkomplexe m-p53/p63, m-p53/p73 und m-p53 abzubrechen und deren verwendungen in der pharmakologie